| __timestamp | ACADIA Pharmaceuticals Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 520990000000 |
| Thursday, January 1, 2015 | 76369000 | 535405000000 |
| Friday, January 1, 2016 | 4406000 | 558755000000 |
| Sunday, January 1, 2017 | 13060000 | 495921000000 |
| Monday, January 1, 2018 | 18330000 | 659690000000 |
| Tuesday, January 1, 2019 | 19598000 | 1089764000000 |
| Wednesday, January 1, 2020 | 20550000 | 994308000000 |
| Friday, January 1, 2021 | 19141000 | 1106846000000 |
| Saturday, January 1, 2022 | 10166000 | 1244072000000 |
| Sunday, January 1, 2023 | 45731000 | 1431505000000 |
| Monday, January 1, 2024 | 1431505000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Takeda Pharmaceutical Company Limited and ACADIA Pharmaceuticals Inc. from 2014 to 2023. Over this period, Takeda consistently reported a significantly higher cost of revenue, peaking at approximately 1.43 trillion in 2023, reflecting its expansive global operations. In contrast, ACADIA's cost of revenue remained relatively modest, with a peak of around 76 million in 2015, highlighting its focused niche market strategy.
Interestingly, Takeda's cost of revenue increased by about 175% from 2014 to 2023, while ACADIA experienced fluctuations, with a notable dip in 2016. This disparity underscores the diverse operational scales and market strategies of these two pharmaceutical giants. The data for 2024 is incomplete, indicating potential shifts in the coming years.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs Takeda Pharmaceutical Company Limited
Cost of Revenue Comparison: Takeda Pharmaceutical Company Limited vs Xenon Pharmaceuticals Inc.
Who Generates More Revenue? Takeda Pharmaceutical Company Limited or ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Mesoblast Limited
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Takeda Pharmaceutical Company Limited vs Xencor, Inc.
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Biogen Inc. and ACADIA Pharmaceuticals Inc.
Cost of Revenue Trends: Xenon Pharmaceuticals Inc. vs ACADIA Pharmaceuticals Inc.
Cost of Revenue: Key Insights for ACADIA Pharmaceuticals Inc. and Supernus Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: ACADIA Pharmaceuticals Inc. vs MiMedx Group, Inc.